nach oben

Journal of Genetic Counseling

Erschienen in:

01.12.2014 | Original Research

Making the Decision to Participate in Predictive Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy

verfasst von: April Manuel, Fern Brunger

Erschienen in: Journal of Genetic Counseling | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

This paper describes the experience of predictive genetic testing for Arrhythmogenic Right Ventricular Cardiomyopathy in the context of novel gene discovery. Two approaches to making the decision to engage in genetic testing were apparent: the decision to be tested either (a) develops gradually over time or (b) happens so quickly that it is felt as a “fait accompli.” Six key factors that influenced the particular approach taken by the participants were identified: (1) scientific process—available and relevant predictive genetic test; (2) numerous losses or deaths within the family; (3) physical signs and symptoms of disease; (4) gender; (5) sense of relational responsibility or moral obligation to other family members; and (6) family support. This study found that at risk individuals juxtapose scientific knowledge against their experiential knowledge and the six identified factors in order to make the decision to participate in genetic testing. Recommendations include the creation of a relational space within which to provide psychological counselling and assessment for the six identified factors that shape the decision to engage in predictive genetic testing.

Ahmad, F., Li, D., Karibe, A., Gonzales, O., Tapscott, T., Hill, R., & Roberts, R. (1998). Localization of a gene responsible for Arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation, 98, 2791–2795. doi:10.1161/01.CIR.98.25.2791.PubMedCrossRef

Andersen, J., Oyen, N., Bjorvatn, C., & Gjengedal, E. (2008). Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death. J Genet Couns, 17, 489–498. doi:10.1007/s10897-008-9167-y.PubMedCrossRef

Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers, 9, 1251–1254. Retrieved from http://cebp.aacrjournals.org/content/9/11/1251.full.pdf+html.

Binedell, J., Soldan, J. R., & Harper, P. S. (1998). Predictive testing for huntington’s disease: predictors of uptake in South Wales. Clin Genet, 54, 477–88. doi:10.1111/j.1399-0004.1998.tb03768.x.PubMedCrossRef

Blumer, H. (1969). Symbolic interactionism. Perspective and method. New Jersey: Prentice-Hall.

Boenink, M., & van der Burg, S. (2010). Informed decision making about predictive DNA tests: arguments for more public visibility of personal deliberations about the good life. Med Health Care Philos, 13, 127–138. doi:10.1007/s11019-009-9227-6.PubMedCentralPubMedCrossRef

Bombard, Y., Penziner, E., Suchowersky, O., Guttman, M., Jane, S. P., & Joan, L. B. (2008). Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease. Eur J Hum Genet, 16, 279–89. doi:10.1038/sj.ejhg.5201937.PubMedCentralPubMedCrossRef

Bruno, M., Tommasi, S., Stea, B., Quaranta, M., Schittulli, F., & Mastropasqua, A. (2004). Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Ann Oncol, 15(1), I48–I54. doi:10.1093/annonc/mdh658.PubMedCrossRef

Cameron, L. D., Sherman, S., Marteau, T., & Brown, P. (2009). Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol, 28, 307–16. doi:10.1037/a0013947.PubMedCrossRef

Chivers Seymour, K., Addington-Hall, J., Lucassen, A. M., & Foster, C. L. (2010). What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research. J Genet Couns, 19, 330–342. doi:10.1007/s10897-010-9296-y.PubMedCrossRef

Christiaans, I., Birnie, E., Bonsel, G. J., Wilde, A. M., & van Lange, I. M. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet, 16, 1201–1207. doi:10.1038/ejhg.2008.92.PubMedCrossRef

Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. M., & Smets, E. M. A. (2009). Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A, 149, 602–612. doi:10.1002/ajmg.a.32710.CrossRef

Codori, A. M., Petersen, G. M., Boyd, P. A., Brandt, J., & Giardiello, F. M. (1996). Genetic testing for cancer in children. short-term psychological effect. Arch Pediatr Adolesc Med, 150, 1131–1138.PubMedCrossRef

Codori, A. M., Zawacki, K. L., Petersen, G. M., Miglioretti, D. L., Bacon, J. A., Trimbath, J. D., & Giardiello, F. M. (2003). Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A, 116A(2), 117–128. doi:10.1002/ajmg.a.10926.PubMedCrossRef

Corrado, D., Fonatine, G., Marcus, F. I., Mckenna, W. J., Nava, A., Thiene, G., & Wichter, T. (2000). Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation, 101, e101–e106. doi:10.1161/01.CIR.101.11.e101.PubMedCrossRef

Cox, S. M. (2003). Stories in decisions: how at-risk individuals decide to request predictive testing for Huntington disease. Qual Sociol, 26(2), 257–280. Retrieved from http://web.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=d7522ca7-f10e-4de9-8eed-9f67e4fea451%40sessionmgr113&vid=2&hid=112.CrossRef

Cox, S. M., & McKellin, W. (1999). There’s this thing in our family’: predictive testing and the construction of risk for Huntington disease. Sociol Health Illn, 21, 622–646. doi:10.1111/1467-9566.00176.CrossRef

Cox, M. G. P. J., van der Smagt, J. J., Noorman, M., Wiesfeld, A. C., Volders, P. G. A., van Langen, I. M., & Hauer, R. N. W. (2010). Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria. Impact of new task force criteria. Circ Arrhythm Electrophysiol, 3(2), 126–133. doi:10.1161/CIRCEP.109.927202.PubMedCrossRef

d’Agincourt-Canning, L. (2005). The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns, 14(1), 55–69. doi:10.1007/s10897-005-1500-0.PubMedCrossRef

d’Agincourt-Canning, L. (2001). Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics, 15, 231–247. doi:10.1111/1467-8519.00234.PubMedCrossRef

d’Agincourt-Canning, L. (2006a). A gift or a yoke? women’s and men’s responses to genetic risk information from BRCA1 and BRCA2 testing. Clin Genet, 70, 462–472. doi:10.1111/j.1399-0004.2006.00720.x.PubMedCrossRef

d’Agincourt-Canning, L. (2006b). Genetic testing for hereditary breast and ovarian cancer: responsibility and choice. Qual Health Res, 16(1), 97–118. doi:10.1177/1049732305284002.PubMedCrossRef

Davison, C., Frankel, S., & Smith, G. D. (1989). Inheriting heart trouble: the relevance of common-sense ideas to preventive measures. Health Educ Res, 4, 329–340. doi:10.1093/her/4.3.329.CrossRef

Davison, C., Smith, G. D., & Frankel, S. (1991). Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. Sociol Health Illn, 13, 1–19. doi:10.1111/j.1467-9566.1991.tb00085.x.CrossRef

Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cloostermans, T., Cassiman, J. J., Demyttenaere, K., & Van den Berghe, H. (1997). Non-participation in predictive testing for Huntington’s disease: individual decision-making, personality and avoidant behaviour in the family. Eur J Hum Genet, 5, 351–363. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9450179.PubMed

Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., & Dom, R. (2003). Psychological distress in the 5-year period after predictive testing for Huntington’s disease. Eur J Hum Genet, 11(1), 30–38. doi:10.1038/sj.ejhg.5200913.PubMedCrossRef

Douma, K. F., Aaronson, N. K., Vasen, H. F., & Bleiker, E. M. (2008). Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psychooncology, 17, 737–745. doi:10.1002/pon.1357.PubMedCrossRef

Duncan, R. E., Gillam, L., Savulescu, J., Williamson, R., John, G. R., & Martin, B. D. (2007). “Holding your breath”: interviews with young people who have undergone predictive genetic testing for Huntington disease. Am J Med Genet A, 143A, 1984–1989. doi:10.1002/ajmg.a.31720.PubMedCrossRef

Esplen, M. J., Madlensky, L., Butler, K., McKinnon, W., Bapat, B., Wong, J., & Gallinger, S. (2001). Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet A, 103, 9–15. doi:10.1002/ajmg.1493.CrossRef

Etchegary, H. (2005). I have the gene, but I don’t have Huntington disease: Negotiating genetic risk. (Doctoral dissertation). Retrieved from ProQuest.

Etchegary, H. (2006). Genetic testing for Huntington’s disease: how is the decision taken? Genet Test, 10(1), 60–67. doi:10.1089/gte.2006.10.60.PubMedCrossRef

Etchegary, H. (2009). Coping with genetic risk: living with Huntington disease (HD). Curr Psychol, 28, 284–301. doi:10.1007/s12144-009-9061-2.CrossRef

Etchegary, H. (2010). ‘I put it on the back burner most days’: living with chronic risk. Health, 15, 633–649. doi:10.1177/1363459310364162.PubMed

Etchegary, H., & Fowler, K. (2008). They had the right to know. Genetic risk and perceptions of responsibility. Psychol Health, 23, 707–727. doi:10.1080/14768320701235249.PubMedCrossRef

Evers-Kiebooms, G., & Decruyenaere, M. (1998). Predictive testing for Huntington’s disease: a challenge for persons at risk and for professionals. Patient Educ Couns, 35(1), 15–26. doi:10.1016/S0738-3991(98)00086-X.PubMedCrossRef

Evers-Kiebooms, G., Nys, K., Harper, P., Zoeteweij, M., Durr, A., Jacopini, G., & Simpson, S. (2002). Predictive DNA-testing for Huntington’s disease and reproductive decision making: a European collaborative study. Eur J Hum Genet, 10, 167–176. doi:10.1038/sj.ejhg.5200781.PubMedCrossRef

Fontaine, G., Fontaliran, F., & Frank, R. (1998). Arrhythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses. Circulation, 97, 1532–1535. doi:10.1161/01.CIR.97.16.1532.PubMedCrossRef

Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., Lerman, B. B., Markowitz, S. M., & Thierfelder, L. (2004). Mutations in the desmosomal protein plakophilin-2 are common in Arrhythmogenic right ventricular cardiomyopathy. Nat Genet, 36, 1162–1164. doi:10.1038/ng1461.PubMedCrossRef

Glaser, B. G. (1978). Theoretical sensitivity. CA: Sociology Press.

Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: strategies for qualitative research. New York: Aldine.

Gollob, M. H., Blier, L., Brugada, R., Champagne, J., Chauhan, V., Connors, S., & Woo, A. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian cardiovascular Society/Canadian heart rhythm society joint position paper. Can J Cardiol, 27, 232–245. doi:10.1016/j.cjca.2010.12.078.PubMedCrossRef

Haddow, G. (2009). “We only did it because he asked us”: gendered accounts of participation in a population genetic data collection. Soc Sci, 69, 1010–1017. doi:10.1016/j.socscimed.2009.07.028.

Hallowell, N. (1999). Doing the right thing: genetic risk and responsibility. Sociol Health, 21, 597–621. doi:10.1111/1467-9566.00175.CrossRef

Hallowell, N., Arden-Jones, A., Eeles, R., Foster, C., Lucassen, A., & Moynihan, C. (2006). Guilt, blame and responsibility: men’s understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health, 28, 969–988. doi:10.1111/j.1467-9566.2006.00515.x.CrossRef

Hodgkinson, K., Dicks, E., Connors, S., Young, T.-L., Parfrey, P., & Pullman, D. (2009). Translation of research discoveries to clinical care in Arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: lessons for health policy in genetic disease. Genet Med, 11, 859–865. doi:10.1097/GIM.0b013e3181c20bb3.PubMedCrossRef

Hodgkinson, K., Connors, S. P., Merner, N., Haywood, A, Young, T-L., McKenna,W.J., … Parfrey, P.S. (2012). The natural history of a genetic subtype of Arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43. Clinical Genetics, 1–11. doi:10.111/j.1399-0004.2012.01919.x

Johnson, E. J., & Tversky, A. (1983). Affect, generalization, and the perception of risk. J Pers Soc Psychol, 45(1), 20–31. doi:10.1037/0022-3514.45.1.20.CrossRef

Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Disclosures of Huntington disease risk within families: patterns of decision-making and implications. Am J Med Genet A, 143A, 1835–1849. doi:10.1002/ajmg.a.31864.PubMedCrossRef

Krimsky, S., & Golding, D. (1992). Social theories of risk. Westport: Praeger Publishers.

Landsbergen, K., Verhaak, C., Kraaimaat, F., & Hoogerbrugge, N. (2005). Genetic uptake in BRCA-mutation families is related to emotional and behavioural communication characteristics of index patients. Fam Cancer, 4(2), 115–119. doi:10.1007/s10689-004-7991-2.PubMedCrossRef

Lerman, C., & Shields, A. E. (2004). Genetic testing for cancer susceptibility: the promise and the pitfalls. Nat Rev Cancer, 4, 235–241. doi:10.1038/nrc1301.PubMedCrossRef

Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol, 12, 843–850. Retrieved from http://jco.ascopubs.org/content/12/4/843.short.PubMed

Lerman, C., Hughes, C., Lemon, S., Main, D., Snyder, C., Durham, C., & Lynch, H. (1998). What you don’t know can hurt you: adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol, 16, 1650–1654. Retrieved from http://jco.ascopubs.org/content/16/5/1650.short.PubMed

Lock, M., & Nguyen, V.-K. (2010). An anthropology of biomedicine. UK: Wiley.

Lupton, D. (1995). The imperative of health: public health and the regulated body. London: Sage Publications Ltd.

Lupton, D. (1999). Risk and sociocultural theory: new directions and perspectives. New York: Cambridge University Press.

Lupton, D., & Tulloch, J. (2002). ‘Life would be pretty dull without riskʼ: voluntary risk-taking and its pleasures. Health Risk Soc, 4, 113–124. doi:10.1080/13698570220137015.CrossRef

Madlensky, L., Esplen, M. J., Gallinger, S., McLaughlin, J. R., & Goel, V. (2003). Relatives of colorectal cancer patients: factors associated with screening behaviour. Am J Prev Med, 25, 187–194. doi:10.1016/S0749-3797(03)00202-2.PubMedCrossRef

Manuel, A. (2013). Constructing the meaning of being at-risk: the experiences of individuals living in families at risk for Arrhythmogenic right ventricular cardiomyopathy in the province of Newfoundland and Labrador: a grounded theory study (Unpublished doctoral dissertation). Newfoundland: Memorial University of Newfoundland.

Marcus, F. I., Fontaine, G. H., Guiraudon, G., Frank, R., Laurenceau, J. L., Malergue, C., & Grosgogeat, Y. (1982). Right ventricular dysplasia: a report of 24 cases. Circulation, 65, 384–398. doi:10.1161/01.CIR.65.2.384.PubMedCrossRef

Marshall, W. H., Furey, M., Larsen, B., Rose, J., Sharratt, G. P., Sussex, B., & Virmani, S. (1988). Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med, 319, 174–175. doi:10.1056/NEJM198807213190312.CrossRef

McAllister, M. (2002). Predictive genetic testing and beyond: a theory of engagement. J Health Psychol, 7, 491–505. doi:10.1177/1359105302007005628.PubMedCrossRef

McAllister, M. (2003). Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet, 64, 179–189. doi:10.1034/j.1399-0004.2003.00133.x.PubMedCrossRef

Mead, G. H. (1934). Mind, self, and society. Chicago: University of Chicago Press.

Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology, 14, 1060–1074. doi:10.1002/pon.933.PubMedCrossRef

Meiser, B., Gaff, C., Julian-Reynier, C., Biesecker, B. B., Esplen, M. J., Vodermaier, A., & Tibben, A. (2007). International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis, 27(1), 109–125. Retrieved from http://iospress.metapress.com/content/y5465m7627n585x6/.

Merner, N. D., Hodgkinson, K. A., Haywood, A. F. M., Connors, S., French, V. M., Drenckhahn, J. D., & Young, T. L. (2008). Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet, 82, 809–821. doi:10.1016/j.ajhg.2008.01.010.PubMedCentralPubMedCrossRef

Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: a study of emotional impact. J Med Genet, 38, 519–526. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1734924/pdf/v038p00519.pdf.PubMedCentralPubMedCrossRef

Morse, J. M. (1994). Designing funded qualitative research. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 220–235). Thousand Oaks: Sage.

Nelkin, D. (1992). The rhetoric of scientific revolution. Hastings Cent Rep, 22(4), 38–39.PubMedCrossRef

Norris, J., Spelic, S., Snyder, C., & Tinley, S. (2009). Five families living with hereditary breast and ovarian cancer risk. Clin J Oncol Nurs, 13(1), 73–80. doi:10.1188/09.CJON.73-80.PubMedCrossRef

Ozanne, E. M., Wittenberg, E., Garber, J. E., & Weeks, J. C. (2010). Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J, 16(1), 38–47. doi:10.1111/j.1524-4741.2009.00857.x.PubMedCrossRef

Parsons, E., & Atkinson, P. (1992). Lay constructions of genetic risk. Sociol Health Illn, 14, 437–55. doi:10.1111/j.1467-9566.1992.tb00131.x.CrossRef

Quaid, K. A., & Morris, M. (1993). Reluctance to undergo predictive testing: the case of Huntington disease. Am J Med Genet, 45, 41–45. doi:10.1002/ajmg.1320450112.CrossRef

Rapp, R. (1999). Testing women, testing the fetus. The social impact of amniocentesis in America. New York: Routledge.

Sanders, T., Campbell, R., Donovan, J., & Sharp, D. (2007). Narrative accounts of hereditary risk: knowledge about family history, lay theories of disease, and “internal” and “external” causation. Qual Health Res, 17, 510–50. doi:10.1177/1049732306297882.PubMedCrossRef

Sherwin, S. (1998). A relational approach to autonomy in health care. In S. Sherwin (Ed.), The politics of women’s health (pp. 19–47). Philadelphia: Temple University Press.

Shiloh, S., & Ilan, S. (2005). To test or not to test? moderators of the relationship between risk perceptions and interest in predictive genetic testing. J Behav Med, 28(5), 467–479. doi:10.1007/s10865-005-9017-4.PubMedCrossRef

Shiloh, S., & Saxe, L. (1989). Perception of risk in genetic counseling. Psychol Health, 3(1), 45–61. doi:10.1080/08870448908400365.CrossRef

Shiloh, S., Gerad, L., & Goldman, B. (2006). Patients’ information needs and decision-making processes: what can be learned from genetic counselees. Health Psychol, 25(2), 211–219. doi:10.1037/0278-6133.25.2.211.PubMedCrossRef

Smart, A. (2010). Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and long QT syndrome: a qualitative study of patient experiences. J Genet Couns, 19, 630–639. doi:10.1007/s10897-010-9314-0.PubMedCrossRef

Smets, E. M. A., Stam, M. M. H., Meulenkamp, T. M., van Langen, I. M., Wilde, A. A. M., Wiegman, A., & Tibben, A. (2008). Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet A, 146A(6), 700–707. doi:10.1002/ajmg.a.32218.PubMedCrossRef

Smith, J. A., Michie, S., Stephenson, M., & Quarrell, O. (2002). Risk perception and decision-making processes in candidates for genetic testing for Huntington’s disease: an interpretative phenomenological analysis. J Health Psychol, 7(2), 131–144. doi:10.1177/1359105302007002398.PubMedCrossRef

Taylor, S. D. (2005). Predictive genetic test decisions for Huntington’s disease: elucidating the test/no-test dichotomy. J Health Psychol, 10, 597–612. doi:10.1177/1359105305053442.PubMedCrossRef

Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med, 318, 129–133. doi:10.1056/NEJM198801213180301.PubMedCrossRef

Thiene, G., Corrado, D., & Basso, C. (2007). Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis, 2(45), 1–16. doi:10.1186/1750-1172-2-45.

van Oostrom, I., Meijers-Heijboer, H., Lodder, L. N., Duivenvoorden, H. J., van Gool, A. R., Seynaeve, C., & Tibben, A. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol, 21, 3867–3874. doi:10.1200/JCO.2003.10.100.PubMedCrossRef

Weiner, K., & Durrington, P. (2008). Patients’ understandings and experiences of familial hypercholesterolemia. Community Genet, 11, 273–282. doi:10.1159/000121398.PubMedCrossRef

Titel: Making the Decision to Participate in Predictive Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy
verfasst von: April Manuel
Fern Brunger
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 6/2014
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-014-9733-4

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Making the Decision to Participate in Predictive Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2014

Attitudes Towards Potentially Carrying the FMR1 Premutation: Before vs After Testing of Non-Carrier Females with Diminished Ovarian Reserve

Demographic and Experiential Correlates of Public Attitudes Towards Cell-Free Fetal DNA Screening

Psychosocial Stressors of Sickle Cell Disease on Adult Patients in Cameroon

Client Views and Attitudes to Non-Invasive Prenatal Diagnosis for Sickle Cell Disease, Thalassaemia and Cystic Fibrosis

An Internal Performance Assessment of CancerGene Connect: An Electronic Tool to Streamline, Measure and Improve the Genetic Counseling Process

Genetic Counseling for Fanconi Anemia: Crosslinking Disciplines

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie